Discussão da tromboprofilaxia em pacientes com Covid-19 / Discussion of thromboprophylaxis in patients with Covid-19
DOI:
https://doi.org/10.34119/bjhrv5n2-084Keywords:
“trombofilaxia farmacológica em Covid-19”, “tromboembolismo pulmonar”, “tromboembolismo no Covid-19”.Abstract
O tromboembolismo pulmonar é a complicação de maior incidência por COVID-19, o que aumenta a morbidade e mortalidade. O biomarcador D-dímero é utilizado para averiguar o risco do paciente ter um evento tromboembólico e determinar a tromboprofilaxia, que pode estar associada ao aumento de sobrevida. Entretanto, o uso em altas doses provoca sangramentos graves e fatais. Desse modo, é imprescindível que haja mais estudos, porém, até o presente momento, a maioria dos trabalhos demonstra que há aumento de sobrevida quando são administrados anticoagulantes profiláticos.
References
SUH, Young Joo et al. Pulmonary embolism and deep vein thrombosis in COVID-19: a systematic review and meta-analysis. Radiology, v. 298, n. 2, p. E70-E80, 2021.
WOODARD, Pamela K. Pulmonary Thromboembolism in COVID-19. Radiology, v. 298, n. 2, p. E107-E108, 2021.
MANOLIS, Antonis S. et al. COVID-19 infection: viral macro-and micro-vascular coagulopathy and thromboembolism/prophylactic and therapeutic management. Journal of Cardiovascular Pharmacology and Therapeutics, v. 26, n. 1, p. 12-24, 2021.
CATTANEO, Marco et al. Pulmonary embolism or pulmonary thrombosis in COVID-19? Is the recommendation to use high-dose heparin for thromboprophylaxis justified?. Thrombosis and haemostasis, v. 120, n. 08, p. 1230-1232, 2020.
FONTANA, Pierre et al. Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines. Swiss medical weekly, v. 150, n. w20301, p. 1-9, 2020.
JENNER, William J. et al. Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review. Journal of thrombosis and thrombolysis, v. 51, n. 3, p. 595-607, 2021.
CHI, Gerald et al. Venous thromboembolism among hospitalized patients with COVID-19 undergoing thromboprophylaxis: a systematic review and meta-analysis. Journal of clinical medicine, v. 9, n. 8, p. 2489, 2020.
JONMARKER, Sandra et al. Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients. Critical Care, v. 24, n. 1, p. 1-10, 2020.
HASAN, Syed Shahzad et al. Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis. Journal of thrombosis and thrombolysis, v. 50, n. 4, p. 814-821, 2020.
